Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Top of the Hill
Use it or lose it has lost it

Posted 17 February 2021 AM

Medicines Australia's response to the Health Department's announcement of the new 'use-it-or-lose-it' rule for positive listing recommendations not acted on by sponsors shows that, at best, the right bureaucratic hand may not know what the left one is doing.

The industry peak body has its eyes firmly focussed on the May Commonwealth budget, by which time both it and the government have indicated they expect a new strategic agreement to be finalised.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Pfizer vs Humira
Adds to a growing list of adalimumab biosims
Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas